Inventor
LONG JIANG
US58 patents
⚠️ This page may combine multiple inventors who share the name “LONG JIANG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ENANTA PHARM INC
41 patentsUS10683279B2Jun 16, 2020
Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
ENANTA PHARM INC13 citations94
US11560368B2Jan 24, 2023
Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
ENANTA PHARM INC6 citations86
US11420976B2Aug 23, 2022
Heterocyclic compounds as anti-viral agents
ENANTA PHARM INC7 citations86
US10988458B2Apr 27, 2021
Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
ENANTA PHARM INC7 citations84
US10584145B2Mar 10, 2020
Process for preparation of sulfonylurea bile acid derivatives
ENANTA PHARM INC8 citations84
US10457703B2Oct 29, 2019
Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof
ENANTA PHARM INC8 citations84
US10450301B2Oct 22, 2019
Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
ENANTA PHARM INC11 citations84
US10253018B2Apr 9, 2019
Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
ENANTA PHARM INC10 citations84
US10246439B2Apr 2, 2019
Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
ENANTA PHARM INC12 citations84
US10208081B2Feb 19, 2019
Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof
ENANTA PHARM INC9 citations84
US9220748B2Dec 29, 2015
Macrocyclic proline derived HCV serine protease inhibitors
ENANTA PHARM INC6 citations84
US8367618B2Feb 5, 2013
Cyclosporin analogues for preventing or treating hepatitis C infection
ENANTA PHARM INC6 citations84
US8367053B2Feb 5, 2013
Cyclosporin analogues
ENANTA PHARM INC9 citations84
US12018017B2Jun 25, 2024
Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
ENANTA PHARM INC1 citations73
US11958879B2Apr 16, 2024
Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof
ENANTA PHARM INC1 citations73
US11834436B2Dec 5, 2023
Tetrazole containing apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
ENANTA PHARM INC2 citations73
US11718641B2Aug 8, 2023
Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof
ENANTA PHARM INC1 citations73
US11040998B2Jun 22, 2021
Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof
ENANTA PHARM INC2 citations73
US10968249B2Apr 6, 2021
Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof
ENANTA PHARM INC3 citations73
US10696713B2Jun 30, 2020
Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof
ENANTA PHARM INC3 citations73
US10472386B2Nov 12, 2019
Bile acid derivatives as FXR agonists and methods of use thereof
ENANTA PHARM INC6 citations73
US10149835B2Dec 11, 2018
Isoxazole derivatives as FXR agonists and methods of use thereof
ENANTA PHARM INC2 citations73
US10080741B2Sep 25, 2018
Isoxazole derivatives as FXR agonists and methods of use thereof
ENANTA PHARM INC3 citations73
US10080742B2Sep 25, 2018
Isoxazole derivatives as FXR agonists and methods of use thereof
ENANTA PHARM INC3 citations73
US10080743B2Sep 25, 2018
Isoxazole derivatives as FXR agonists and methods of use thereof
ENANTA PHARM INC4 citations73
US12552777B2Feb 17, 2026
Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
ENANTA PHARM INC0 citations63
US12459923B2Nov 4, 2025
Tetrazole containing apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
ENANTA PHARM INC0 citations63
US11008304B2May 18, 2021
Tetrazole containing apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
ENANTA PHARM INC1 citations63
US10144729B2Dec 4, 2018
Isoxazole analogs as FXR agonists and methods of use thereof
ENANTA PHARM INC2 citations63
US9221878B2Dec 29, 2015
Cyclosporin analogues for preventing or treating hepatitis C infection
ENANTA PHARM INC3 citations63
US9156886B2Oct 13, 2015
Cyclosporin analogues for preventing or treating hepatitis C infection
ENANTA PHARM INC2 citations63
US8349312B2Jan 8, 2013
Proline substituted cyclosporin analogues
ENANTA PHARM INC4 citations63
US12281140B2Apr 22, 2025
Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof
ENANTA PHARM INC0 citations62
US10947264B2Mar 16, 2021
Process for preparation of sulfonylurea bile acid derivatives
ENANTA PHARM INC0 citations62
US8906853B2Dec 9, 2014
[N-Me-4-hydroxyleucine]-9-cyclosporin analogues for treatment and prevention of hepatitis C infection
ENANTA PHARM INC2 citations58
US11345699B2May 31, 2022
Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
ENANTA PHARM INC0 citations52
US10138228B2Nov 27, 2018
Isoxazole derivatives as FXR agonists and methods of use therof
ENANTA PHARM INC1 citations52
US9616099B2Apr 11, 2017
Cyclosporin analogues for preventing or treating hepatitis C infection
ENANTA PHARM INC0 citations52
US9603895B2Mar 28, 2017
Cyclosporin analogues for preventing or treating hepatitis C infection
ENANTA PHARM INC0 citations52
US8921573B2Dec 30, 2014
Processes for the preparation of novel benzimidazole derivatives
ENANTA PHARM INC2 citations52
US8354383B2Jan 15, 2013
6,11-bridged biaryl macrolides
ENANTA PHARM INC1 citations52
OR YAT SUN
4 patentsUS9085599B2Jul 21, 2015
2′allene-substituted nucleoside derivatives
OR YAT SUN45 citations94
US8648037B2Feb 11, 2014
Macrocyclic proline derived HCV serine protease inhibitors
OR YAT SUN12 citations84
US8481483B2Jul 9, 2013
Cyclosporin analogues
OR YAT SUN9 citations84
US8623814B2Jan 7, 2014
Antiviral agents
OR YAT SUN5 citations73
SHENZHEN FUTAIHONG PREC IND CO
1 patentLONG JIANG
1 patentLONG TAO
1 patentGAO XURI
1 patentMITSUBISHI ELECTRIC RES LAB
1 patentShowing the top 50 of 58 patents by PatentIndex Score.